Symbiotec Pharmalab Adopts Fair Disclosure Code

Symbiotec Pharmalab Ltd has adopted a Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information (UPSI) in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. This code, effective December 15, 2025, aims to ensure timely and adequate disclosure of UPSI to maintain transparency and fairness with stakeholders. It outlines principles for prompt public disclosure of price-sensitive information, uniform dissemination, and handling of inquiries.